Leukotriene Receptors, Their Importance in Medical Practice and the Drugs Acting on Them
Year: 2025
Type: article
Abstract: Strong lipid mediators, leukotrienes (LTs), such as cysteinyl LTs (CysLTs) and LTB4, play a key role in the pathogenesis of asthma symptoms. There are at least two known receptor subtypes for CysLTs: CysLT1 and CysLT2. The activation of the CysLT1 receptor mediates the majority of the pathophysiological consequences of CysLTs in asthma, such as increased airway smooth muscle activity, microvascular permeability, and airway mucus secretion. Asthma exacerbations, severe asthma, and airway hyperresponsiveness may all be influenced by LTB4. CysLT1 receptor antagonists can be administered orally as monotherapy in patients with persistent mild asthma, despite the fact that they are typically less efficacious than inhaled glucocorticoids.
Authors: Rashidov, Sokhib, Yakubova, Nigora, Shaxkhmurova, Madina, Bozorov, Akmal, Abdurasulov, Abdusamad
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W6893201151
FWCI:
Cites:
Cited by:
Related to: